Skip to main content
SpringerLink
Log in

Prophylaxis of Migraine in Children and Adolescents

  • Review Article
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

While it has been established that headaches in the pediatric age group are relatively common, the characterization of headache disorders and their treatment in this group has historically been limited. Due to the paucity of controlled studies on prophylaxis of the primary headache disorders in children, the diagnosis of migraine often rests on criteria similar to those used in adults. Data from adult studies are often extrapolated and applied to the pediatric patient. Although it appears that many prophylactic agents are safe, well tolerated and efficacious in children, currently only topiramate is FDA-approved for use in patients 12 years and over. As a result, despite often experiencing significant disability, many children who present to their physician with migraines do not receive preventive therapy. One-third of adolescents meet the criteria for warranting prophylactic therapy, yet few are offered a preventative medication. Moreover, controlled clinical trials investigating the use of both abortive and prophylactic medications in children have suffered from high placebo response rates. A diverse group of medications are used to prevent migraine attacks, including antidepressants, antiepileptics, antihistamines and antihypertensive agents, yet there still remains a serious lack of controlled studies on the pharmacological treatment of pediatric migraine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lewis D. Pediatric migraine. Neurol Clin. 2009;27:481–501.

    Article  PubMed  Google Scholar 

  2. World Health Organization, Lifting the Burden. Atlas of Headache Disorders and Resources in the World 2011. A collaborative project of World Health Organization and Lifting the Burden. Geneva: World Health Organization; 2011.

    Google Scholar 

  3. Hershey AD. Pediatric headache: update on recent research. Headache. 2012;52(2):327–32.

    Article  PubMed  Google Scholar 

  4. Winner P, Hershey AD. Epidemiology and diagnosis of migraine in children. Curr Pain Headache Rep. 2007;11:375–82.

    Article  PubMed  Google Scholar 

  5. Aydin M, Kabakus N, Bozdag S. Profile of children with migraine. Indian J Pediatr. 2010;77:1247–51.

    Article  PubMed  Google Scholar 

  6. Bille BS. Migraine in school children. A study of the incidence and short-term prognosis, and a clinical, psychological and electroencephalographic comparison between children with migraine and matched controls. Acta Pediatr (Oslo, Norway: 1992) Suppl. 1962:136:1–151.

  7. Abu-Arafeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ. 1994;309:765–9.

    Article  Google Scholar 

  8. Stewart WF, Linet MS, Celentano DD, Van Natta M, Siegler D. Age and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol. 1191;34:1111–20.

  9. Diamond S, Bigal ME, Silberstein S, et al. Patterns of diagnosis and acute and preventative treatment of migraine in the United States. Results of the American Migraine Prevalence and Prevention Study. Headache. 2007;47(9):355–63.

    PubMed  Google Scholar 

  10. Stang PE, Osterhaus JT. Impact of migraine in the United States: data from the International Health Interview Survey. Headache. 1993;33:29–35.

    Article  CAS  PubMed  Google Scholar 

  11. Powers SW, Patton SR, Hommel KA, Hershey AD. Quality of life in paediatric migraine: Characterization of age-related effects using Peds QL 4.0. Cephalalgia. 2004;24:120–7.

    Article  CAS  PubMed  Google Scholar 

  12. Hershey AD. Current approaches to the diagnosis and management of pediatric migraine. Lancet Neurology. 2010;9:190–204.

    Article  CAS  Google Scholar 

  13. Lewis DW, Diamond S, Scott D, Jones V. Prophylactic treatment of pediatric migraine. Headache. 2004;44(3):230–7.

    Article  PubMed  Google Scholar 

  14. Couch JR, Zeigler DK, Hassanein R. Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant effects. Neurology. 1976;26:121–7.

    Article  CAS  PubMed  Google Scholar 

  15. Eidlitz-Markus T, Dlugatch Y, Haimi-Cohen Y, Goldberg-Stern H, Zeharia A. Nonpharmacologic treatment of migraine with low-dose propranolol or amitriptyline. Pediatr Neurol. 2012;46:345–9.

    Article  PubMed  Google Scholar 

  16. Papetti L, Spalice A, Nicita F, Paolino MC, Castaldo R, Iannetti P, Villa MP, Parisi P. Migraine treatment in the developmental age: guidelines update. J Headache Pain. 2010;11(3):267–76.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Hershey AD, Powers SW, Bentii AL, deGrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 2000;40:539–549.

  18. Hershey AD, Powers SW, Coffey CS, Eklund DD, Chamberlin LA, Korbee LL. Childhood and Adolescent Migraine Prevention (CHAMP) Study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline, topiramate, and placebo in prevention of childhood and adolescent migraine. Headache. 2013;53:799–816.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Lewis D, Winner P, Saper J, Ness S, Polverejan E, Wang S, Kurland CL, Nye J, Yuen E, Eerdekens M, Ford L. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics. 2009;123(3):924–34.

    Article  PubMed  Google Scholar 

  20. Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache. 2005;45:1304–12.

    Article  PubMed  Google Scholar 

  21. Winner P, Gendolla A, Stayer C, Wang S, Yuen E, Battisti WP, Nye JS. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety. Headache. 2006;46:1503–10.

    Article  PubMed  Google Scholar 

  22. Hershey AD, Powers SW, Vockell AL, LeCates S, Kabbouche M. Effectiveness of topiramate in the prevention of childhood headaches. Headache. 2002;42:810–8.

    Article  PubMed  Google Scholar 

  23. O’Brien HL, Kabbouche MA, Hershey AD. Treating pediatric migraine: an expert opinion. Expert Opin Pharmacother. 2012;13(7):959–66.

    Article  PubMed  Google Scholar 

  24. Unalp A, Uran N, Ozturk A. Comparison of the effectiveness of topiramate and sodium valproate in pediatric migraine. J Child Neurol. 2008;23:1377–81.

    Article  PubMed  Google Scholar 

  25. Apostol G, Lewis D, Laforet GA, Robieson WZ, Fugate JM, Abi-Saab WM, Salterelli MD. Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study. Headache. 2009;49(1):45–53.

    Article  PubMed  Google Scholar 

  26. Serdaroglu G, Erhan E, Tekgul H, Oksel F, Erermis S, Uyar M, Tutuncuoglu S. Sodium valproate prophylaxis in childhood migraine. Headache. 2002;42:819–22.

    Article  PubMed  Google Scholar 

  27. Bidabadi E, Mashouf M. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients. Paediatr Drugs. 2010;54(3):269–75.

    Article  Google Scholar 

  28. Miller GS. Efficacy and safety of levetiracetam in pediatric migraine. Headache. 2004;44:238–43.

    Article  PubMed  Google Scholar 

  29. Pakalnis A, Kring D, Meier L. Levetiracetam prophylaxis in pediatric migraine—an open-label study. Headache. 2007;43(3):427–30.

    Article  Google Scholar 

  30. Pakalnis A, Kring D. Zonisamide prophylaxis in refractory pediatric headache. Headache. 2006;46(5):804–7.

    Article  PubMed  Google Scholar 

  31. Silberstein S, Goode-Sellers S, Twomey C, Saiers J, Ascher J. Randomized, double-blind, placebo-controlled, phase II trial of gabapentin enacarbil for migraine prophylaxis. Cephalalgia. 2012;33(2):101–11.

    Article  PubMed  Google Scholar 

  32. Belman AL, Milazo M, Savatic M. Gabapentin for migraine prophylaxis in children. Ann Neurol. 2001;50(Suppl 1):S109.

    Google Scholar 

  33. Termine C, Ozge A, Antonaci F, Natriashvili S, Guidetti V, Wober-Bingol C. Overview of diagnosis and management of paediatric headache. Part II: therapeutic management. J Headache Pain. 2011;12(1):25–34.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Johnson A, Bickel J, Lebel A. Pediatric migraine prescription patterns at a large academic hospital. Pediatr Neurol. 2014;51:706–12.

    Article  PubMed  Google Scholar 

  35. Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurologica. 1974;50:109–15.

    Article  CAS  Google Scholar 

  36. Forsythe WI, Gillies D, Sills MA. Propanolol (‘Inderal’) in the treatment of childhood migraine. Dev Med Child Neurol. 1984;26:737–41.

    Article  CAS  PubMed  Google Scholar 

  37. Bonfert M, Straube A, Schroeder AS, Rellich FE, Heinen F. Primary headache in children and adolescents: update on pharmacotherapy of migraine and tension-type headache. Neuropediatrics. 2013;44:3–19.

    Article  CAS  PubMed  Google Scholar 

  38. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American academy of neurology quality standards subcommittee and the practice committee of the child neurology society. Neurology. 2004;63:2215–24.

    Article  CAS  PubMed  Google Scholar 

  39. Sorge F, De Simone R, Marano E, Nolano M, Orefice G, Carrieri P. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia. 1988;8:1–6.

    Article  CAS  PubMed  Google Scholar 

  40. Bernhard MK, Bertsche A, Syrbe S, Weise S, Merkenschlager A. Botulinum toxin injections for chronic migraine in adolescents—an early therapeutic option in the transition from neuropaediatrics to neurology. Fortschr Neurol Psychiatr. 2014;82(1):39–42.

    Article  CAS  PubMed  Google Scholar 

  41. Ahmed K, Oas KH, Mack KJ, Garza I. Experience with botulinum toxin A in medically intractable pediatric chronic daily headache. Pediatr Neurol. 2010;43(5):316–9.

    Article  PubMed  Google Scholar 

  42. Kabbouche MA, O’Brien HL, Hershey AD. OnabotulinumtoxinA in pediatric chronic daily headache. Curr Neurol Neurosci Rep. 2012;12(2):114–7.

    Article  CAS  PubMed  Google Scholar 

  43. Orr S, Venkateswaran S. Neutraceuticals in the prophylaxis of pediatric migraine: Evidence-based review and recommendations. Cephalalgia. 2014;34(8):568–83.

    Article  PubMed  Google Scholar 

  44. Hershey AD, Powers SW, Vockel AL, Lecates SL, Ellinor SL, Segers A, Burdine D, Manning P, Kabbouche MA. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache. 2007;47(1):73–80.

    Article  PubMed  Google Scholar 

  45. Slater SK, Nelson TD, Kabbouche MA, Lecates SL, Horn P, Segers A, Manning P, Powers SW, Hershey AD. A randomized, double-blinded, placebo-controlled, crossover, add on study of coenzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia. 2010;31(8):897–905.

    Article  Google Scholar 

  46. Condo M, Posar A, Arbizzani A, Parmeggiani A. Riboflavin prophylaxis in pediatric and adolescent migraine. J Headache Pain. 2009;10(5):361–5.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Gallai V, Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G. Serum and salivary magnesium levels in migraine. Results in a group of juvenile patients. Headache. 1992;32(3):132–5.

    Article  CAS  PubMed  Google Scholar 

  48. Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults. Neurology. 2012;78:1346–53.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache. 2003;43:601–10.

    Article  PubMed  Google Scholar 

  50. Eidlitz-Markus T, Haimi-Cohen Y, Steier D, Zeharia A. Effectiveness of nonpharmacologic treatment for migraine in young children. Headache. 2010;50:219–23.

    Article  PubMed  Google Scholar 

  51. Bruni O, Galli F, Guidetti V. Sleep hygiene and migraine in children and adolescents. Cephalalgia. 1999;19(Suppl 25):57–9.

    PubMed  Google Scholar 

  52. Millichap JG, Ye MM. The diet factor in pediatric and adolescent migraine. Pediatr Neurol. 2003;28:9–15.

    Article  PubMed  Google Scholar 

  53. Blume HK, Brockman LN, Breuner CC. Biofeedback therapy for pediatric headache: factors associated with response. Headache. 2012;52(9):1377–86.

    Article  PubMed  Google Scholar 

  54. Powers SW, Mitchell MJ, Byars KC, Bentti AL, LeCates SL, Hershey AD. A pilot study of one-session biofeedback training in pediatric headache. Neurology. 2001;56(1):133.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The author has no conflicts of interest to report. No funding was received for the preparation of this review.

Author information

Authors and Affiliations

  1. Division of Neurology, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Ave-MLC 2015, Cincinnati, OH, 45229-3039, USA

    Joanne Kacperski

  2. Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH, USA

    Joanne Kacperski

Authors
  1. Joanne Kacperski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joanne Kacperski.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kacperski, J. Prophylaxis of Migraine in Children and Adolescents. Pediatr Drugs 17, 217–226 (2015). https://doi.org/10.1007/s40272-015-0125-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40272-015-0125-5

Keywords

Search

Navigation